文献速递生殖医学母胎医学

3 044例备孕及孕早期夫妇携带者筛查与高风险家系产前诊断分析

[Carrier screening and prenatal diagnosis analysis of high-risk cases in 3 044 preconception and early pregnancy couples].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2025-01-01

2022年8月至2023年8月在解放军总医院招募1 533个育龄期家系共3 044例受试者,对223个基因进行携带者筛查。总体携带率为52.66%(1 603/3 044),携带率最高的基因为GJB2(8.67%)、CYP21A2(3.19%)和PAH(3.09%)。识别高风险家系38个,筛查可有效识别高风险家系并提供生育指导以阻断患儿出生。

要点

  • 3 044例受试者中总体携带率为52.66%(1 603/3 044),人均携带0.75个变异。
  • 携带率最高的前3位基因为GJB2(8.67%)、CYP21A2(3.19%)、PAH(3.09%)。
  • 识别高风险家系38个,除外G6PD变异后33个,进一步除外GJB2 c.109G>A后21个。

核心结论

  • 携带者筛查可有效识别遗传病高风险家系并提供生育指导,从而有效阻断遗传病患儿出生。
  • 需建立多学科团队应对复杂病例,建议在具备单基因遗传病咨询和诊断能力或转诊体系的机构实施。

研究设计与样本

  • 2022年8月至2023年8月在解放军总医院招募育龄期家系1 533个,共3 044例受试者。
  • 对受试者进行223个基因检测,包括197个常染色体隐性遗传基因和26个X连锁遗传基因。
  • 根据筛查结果提供遗传咨询和生育指导,对高风险夫妇进行侵入性产前诊断并随访妊娠方式、结局及子代表型。

主要发现

  • 1 533个家系中1 503个选择同步筛查,30个选择序贯筛查。
  • 3 044例受试者中1 603例携带至少1个致病性或可能致病性变异,总体携带率为52.66%(1 603/3 044)。
  • 检出致病性或可能致病性变异共计2 292个,人均携带0.75个(2 292/3 044)变异。
  • 携带率最高的前3位基因依次为GJB2(8.67%,264/3 044)、CYP21A2(3.19%,97/3 044)、PAH(3.09%,94/3 044)。
  • 携带率≥1/200的基因32个,≥1/100的基因17个,≥1/50的基因7个。

关键数值与推荐

  • 识别出高风险家系38个;除外G6PD基因变异后高风险家系33个,其中夫妇为相同常染色体隐性遗传基因携带者25个,女方为X连锁基因携带者9个,1个家系为常染色体隐性遗传和X连锁的双高风险夫妇。
  • 进一步除外GJB2基因c.109G>A位点变异后,高风险家系21个。
  • 经遗传咨询后12个备孕期高风险家系选择胚胎植入前单基因病检测。
  • 5个已自然受孕的高风险家系中4个家系完成产前诊断:2例胎儿携带父母变异均选择引产,1例胎儿不携带父母变异但因21三体综合征引产,1例胎儿为先天性糖基化障碍1a型携带者继续妊娠。

临床怎么用

  • 对育龄期人群按标准化入组流程进行携带者筛查,并根据结果为受试者提供遗传咨询和生育指导。
  • 对夫妇双方均为同一常染色体隐性遗传病致病基因携带者或女方为X连锁疾病致病基因携带者的高风险夫妇进行侵入性产前诊断。
  • 作者建议在具备单基因遗传病咨询和诊断能力或转诊体系的机构实施携带者筛查,并建立多学科团队应对复杂病例。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To carry out carrier screening among people of childbearing age, detect the pathogenic genes of monogenic genetic diseases and analyze the carrier status of pathogenic variants, so as to provide fertility guidance and intervention measures for high-risk families. Methods: From August 2022 to August 2023, 1 533 families of childbearing age who met the criteria were recruited in the Chinese PLA General Hospital, including a total of 3 044 subjects. According to the standard enrollment procedure, 223 genes (197 autosomal recessive genes and 26 X-linked genes) of the subjects were tested. According to the screening results, genetic counseling and fertility guidance were provided to the subjects. Invasive prenatal diagnosis was performed for high-risk couples (both couples being carriers of the same autosomal recessive disease gene or the woman was a carrier of X-linked disease gene), and their pregnancy pattern, outcome and offspring phenotype were followed up. Results: (1) A total of 3 044 cases from 1 511 couples and women of childbearing age from 22 families were included for carrier screening. Totally 1 503 families chose simultaneous screening and 30 families chose sequential screening out of the 1 533 families. Among the 3 044 subjects, 1 603 individuals carried at least one pathogenic or likely pathogenic variant, and the overall carrier rate was 52.66% (1 603/3 044). A total of 2 292 pathogenic or likely pathogenic variants were detected, and 0.75 variants (2 292/3 044) were detected per capita. (2) The three genes with the highest carrier rates were GJB2 (8.67%, 264/3 044), CYP21A2 (3.19%, 97/3 044) and PAH (3.09%, 94/3 044). There were 32 genes with a carrier rate ≥1/200, 17 genes with a carrier rate ≥1/100, and 7 genes with a carrier rate ≥1/50. (3) Thirty-eight high-risk families were identified. After excluding G6PD gene mutation, there were 33 high-risk families, of which 25 couples were carriers of the same autosomal recessive gene, 9 women were carriers of X-linked gene, and 1 family was double high-risk couple with both autosomal recessive and X-linked gene. After further excluding the GJB2 c.109G>A mutation, 21 high-risk families were identified. Preimplantation genetic testing for monogenic disease was performed in 12 families after genetic counseling. Prenatal diagnosis was completed in 4 out of 5 high-risk families who conceived naturally. Two fetuses carried the parental variants and terminated the pregnancy, one fetus did not carry the parental variants but was induced due to trisomy 21 syndrome, and one fetus was a carrier of congenital disorders of glycosylation type 1a. Conclusions: Carrier screening effectively identifies high-risk genetic disease families and provides reproductive guidance to prevent the birth of affected children. However, establishing multidisciplinary team is essential for managing complex cases. Implementation should prioritize prenatal institutions with genetic counseling or diagnostic expertise for monogenic disorders or established referral networks. 目的: 对育龄期人群开展携带者筛查,检测单基因遗传病致病基因并分析致病变异携带情况,为高风险家系提供生育指导及干预措施。 方法: 2022年8月至2023年8月在解放军总医院招募育龄期家系1 533个,共计3 044例受试者,按照标准化入组流程,对受试者进行基因检测(共223个基因,其中常染色体隐性遗传基因197个和X连锁遗传基因26个),并根据筛查结果为受试者提供遗传咨询、生育指导。对受孕的高风险夫妇(夫妇双方均为同一常染色体隐性遗传病致病基因的携带者或女方为X连锁疾病致病基因的携带者)进行侵入性产前诊断,随访其妊娠方式、结局及子代表型等。 结果: (1)共纳入1 511个家系中的夫妇和22个家系中的育龄期妇女共计3 044例进行携带者筛查。1 533个家系中,1 503个选择同步筛查,30个选择序贯筛查。3 044例受试者中,1 603例携带至少1个致病性或可能致病性变异,总体携带率为52.66%(1 603/3 044)。检出致病性或可能致病性变异共计2 292个,人均携带0.75个(2 292/3 044)变异。(2)检测范围内,携带率最高的前3位基因依次为GJB2(8.67%,264/3 044),CYP21A2(3.19%,97/3 044),PAH(3.09%,94/3 044)。携带率≥1/200的基因32个,携带率≥1/100的基因17个,携带率≥1/50的基因7个。(3)识别出高风险家系38个;除外G6PD基因变异后高风险家系33个,其中夫妇为相同常染色体隐性遗传基因携带者25个,女方为X连锁基因携带者9个,1个家系为常染色体隐性遗传和X连锁的双高风险夫妇;进一步除外GJB2基因c.109G>A位点变异后,高风险家系21个。经充分的遗传咨询后,12个备孕期高风险家系选择胚胎植入前单基因病检测;5个已自然受孕的高风险家系中4个家系完成了产前诊断,2例胎儿携带其父母的变异,均选择引产,1例胎儿不携带其父母的变异,但因21三体综合征引产,1例胎儿为先天性糖基化障碍1a型携带者,继续妊娠。 结论: 携带者筛查可有效识别遗传病高风险家系并提供生育指导,从而有效阻断遗传病患儿出生,但需建立多学科团队应对复杂病例,建议在具备单基因遗传病咨询和诊断能力或转诊体系的机构实施。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Fu XL, Hou W, Zhang ML, et al. [Carrier screening and prenatal diagnosis analysis of high-risk cases in 3 044 preconception and early pregnancy couples]. Zhonghua Fu Chan Ke Za Zhi. 2025. PMID: 40159040. doi:10.3760/cma.j.cn112141-20240928-00531

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。